Chemomab Therapeutics (CMMB)CEO bought ~$10K

~$10K

Approx. value · 4,878 sh @ $2.05

134K

Holds after · shares reported

Traded

May 29, 2026

Filed

Jun 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 29, 2026 · this disclosureInsider · Bought outside the usual windowCEO purchased ~$10K of CMMB shares in the open market

What came next

1. May 29, 2026Insider · Bought outside the usual windowCEO purchased ~$10K of CMMB shares in the open market
2. Aug 27, 2026InsiderDirector sold ~$3.7K of CMMB shares in the open market
3. Aug 28, 2026InsiderDirector sold ~$2.8K of CMMB shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Chemomab Therapeutics

For Chemomab Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CMMB page.

Other recent filings by George Adi Mor, Chief Executive Officer

• SEC Form 4 at Chemomab Therapeutics (CMMB)Jun 1, 2026

The full history of George Adi Mor, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Chemomab Therapeutics

• SEC Form 4Sep 1, 2026
• SEC Form 4Sep 1, 2026
• SEC Form 4Jun 1, 2026

Everything OQRO holds on this company is on its CMMB page.